Standard of care medical management

OTHER2 trials

Sponsors

CVRx, Inc., Cerenovus, Part of DePuy Synthes Products, Inc.

Conditions

Chronic Subdural HematomaHypertension

Phase 2

Rheos Feasibility Trial

CompletedNCT01077180

CVRx, Inc.Hypertension

Start: 2005-01-31End: 2010-10-31Updated: 2019-07-02

Unknown Phase

Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

CompletedNCT04816591

Cerenovus, Part of DePuy Synthes Products, Inc.Chronic Subdural Hematoma

Start: 2021-05-27End: 2025-03-26Updated: 2026-08-28

Related Papers

Middle Meningeal Artery Embolization With n-Butyl Cyanoacrylate in Patients With Chronic Subdural Hematoma

JAMA Neurology2026-06-15

Middle Meningeal Artery Embolization with n‐Butyl Cyanoacrylate for the Treatment of Subdural Hematomas: The MEMBRANE Study Design

Stroke Vascular and Interventional Neurology2025-09-17

Managing non-acute subdural hematoma using liquid materials: a Chinese randomized trial of middle meningeal artery treatment (MAGIC-MT)-protocol.

2023-09-1413 citations